Presentation is loading. Please wait.

Presentation is loading. Please wait.

Chapter 8. Nucleotide Metabolism

Similar presentations


Presentation on theme: "Chapter 8. Nucleotide Metabolism"— Presentation transcript:

1 Chapter 8. Nucleotide Metabolism
Functions of nucleotites: They are precursors of DNA and RNA ATP is a universal currency of energy Physiological mediators (cAMP, cGMP) They are activated intermediates in many biosynthesis (UDP-glucose, CDP-choline) Adenine nucleotides are components of some coenzymes (NAD+, NADP+ and FAD )

2 1. Biosynthesis of purine nucleotites:
1) The origins of the atoms in the purine ring: One C unit One C unit

3 2) Formation of phosphoribosylamine
Ribose 5-phosphate PRPP ATP ADP PRPP synthase PRPP: 5-Phosphoribose-1-pyrophosphate

4 Glutamine glutamate + PPi
PRPP phosphoribosyl-1-amine Glutamine glutamate + PPi Gln PRPP Amidotransferase

5 3) Formation of inosinate (IMP)

6 4) Formation of AMP and GMP

7 5) Formation of ATP and GTP
AMP ADP ATP GMP GDP GTP Kinase Phosphorylation Pi ATP ADP Kinase Kinase ATP ADP ATP ADP

8 6) Regulation of purine nucleotite synthesis
Feedback inhibitors: AMP, ADP, GMP, GDP, IMP AMP ADP ATP R-5-P PRPP PRA IMP GMP GDP GTP PRA: 5-phosphoribosyl-1-amine activation inhibition

9 7) Salvage pathways for purine nucleotite synthesis
PRPP Purine ribonucleotide Adenine + PRPP AMP + PPi Hypoxanthine + PRPP IMP + PPi Guanine + PRPP GMP + PPi Adenosine + ATP AMP +ADP

10 8) Biosynthesis of deoxyribonucleotides (At the NDP level)
Ribonucleoside deoxyribonucleoside diphosphate diphosphate Base=purine or pyrimidine

11 The mechanism for ribonucleotide reduction:
NDP dNDP Ribonucleotide SH reductase SH Ribonucleotide S reductase S Thioredoxin S S Thioredoxin SH SH Thioredoxin reductase FADH2 FAD NADPH + H+ NADP+

12 8) Inhibition of purine nucleotide biosynthesis by some anticancer drugs
Reaction Inhibitor PRPP PRA mercaptopurine(6MP) Glycinamide ribonucleotide Methotrexate(MTX) Formylglycinamide ribonucleotide Formylglycinamide ribonucleotide Azaserine Formylglycinamidine ribonucleotide IMP AMP MP IMP GMP MP, Azaserine Adenine AMP MP Guanine GMP MP

13

14 2. Degradation of purine nucleotides:
AMP IMP Hypoxanthine Xanthine Uric acid GMP Guanine Xanthine Uric acid

15

16 Gout is induced by high serum levels of urate, a disease that affects the joints and kidneys.
Allopurinol is an analog of hypoxanthine. It is extensively used to treat gout. In the body, allopurinol is converted into alloxanthine, which then remains tightly bound to the active site of xanthine oxidase and thus inhibits the production of urate.

17 3. Synthesis of pyrimidine nucleotides:
1) Origins of the atoms in the pyrimidine ring C N C C C N Carbamoyl phosphate Aspartate

18 2) Pathway of pyrimidine nucleotide synthesis
Formation of carbamoyl phosphate 2ATP + HCO ADP+ Pi Gln Glu

19 Differences between carbamoyl phosphate biosynthesis in the pyrimidine pathway and that in the urea cycle In pyrimidine pathway In urea cycle Location Cytosol Mitochondria -NH2 from: Gln NH4+ Enzyme Carbamoyl phosphate Carbamoyl phosphate synthase-II synthase-I N-acetyl-Glu No effect Activator

20 B) Formation of orotate

21 C) Formation of UMP

22 C) Formation of other pyrimidine nucleotides
UMP UDP UTP ATP ADP ATP ADP Kinase Kinase

23 UDP dUDP dUTP dUTP dUMP NADPH NADP+, H2O ATP ADP Ribonucleotide
reductase Kinase H2O PPi dUTPase

24 - - D) Regulation of pyrimidine nucleotide synthesis CO2 + Gln + ATP
Carbamoyl phosphate N-Carbamoylaspartate UMP - Inhibited by UMP - Inhibited by CTP

25 3) Salvage pathway for pyrimidine nucleotide biosynthesis
Pyrimidine Pyrimidine ribonucleoside monophosphate Orotate Orotidylate UMP PRPP PPi Pyrimidine Phosphoribosyl transferase PRPP PPi H CO2 Orotate Phosphoribosyl transferase Orotidylate decarboxylase

26 4) Anticancer drugs that block the pyrimidine nucleotide biosynthesis
A) 5-Fluorouracil (5-FU): is converted in vivo into fluorodeoxyuridylate (F-dUMP), which is an analog of dUMP and irreversibly inhibits thymidylate synthase.

27 B) Aminopterin and methotrexate (MTX): both are analogs of dihydrofolate. They are potent competitive inhibitors of dihydrofolate reductase and thus block the reactions using one-carbon units.

28 C) Cytosine arabinoside and azaserine: Cytosine arabinoside is an analog of cytosine riboside and thus inhibits the reduction of CDP to dCDP, while azaserine inhibits the conversion of UTP to CTP.

29 - - - - Azaserine UMP UTP CTP CDP dCDP UDP dUDP dUMP dTMP 5-FU
Cytosine arabinoside Azaserine - - 5-FU - - Aminopterin

30 4. Degradation of pyrimidine nucleotide
The pyrimidine ring can be completely degraded in humans. The products include: NH3, CO2, b-alanine, and b-aminoisobutyrate. Both b-alanine, and b-aminoisobutyrate can be further converted into acetyl-CoA and succinyl-CoA, respectively, or are excreted in the urine.

31

32

33 5. Dysmetabolism of nucleotides
Disease Deficiency Symptoms Gout PRPP synthetase hyper uricemia Lesch-Nyhan HGPRT purine and uric syndrom acid, cerebral paralysis Immunodeficiency adenosine deaminase deoxyadenosine Diseases uria, dysostosis Kidney stone APRT kidney stone, urodynia, hematuria Xanthinuria xanthine oxidase kidney stone, no symptoms


Download ppt "Chapter 8. Nucleotide Metabolism"

Similar presentations


Ads by Google